Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008;3(3):473-82.
doi: 10.2147/cia.s2777.

Age-related macular degeneration and the aging eye

Affiliations
Review

Age-related macular degeneration and the aging eye

Rita Ehrlich et al. Clin Interv Aging. 2008.

Abstract

Age-related macular degeneration (AMD) is an ocular disease that causes damage to the retinal macula, mostly in the elderly. Normal aging processes can lead to structural and blood flow changes that can predispose patients to AMD, although advanced age does not inevitably cause AMD. In this review, we describe changes that occur in the macular structure, such as the retinal pigment epithelium and Bruch's membrane, with advancing age and in AMD. The role of genetics in AMD and age-related changes in ocular blood flow that may play a role in the pathogenesis of AMD are also discussed. Understanding the pathophysiology of AMD development can help guide future research to further comprehend this disease and to develop better treatments to prevent its irreversible central vision loss in the elderly.

PubMed Disclaimer

Figures

Figure 1
Figure 1
An illustration of the late form of AMD, showing the growth of the choroidal neovascularization from the choroicapillaris through the Bruch’s membrane into the subretinal space. These new vessels are abnormal and have a higher tendency of leakage and bleeding. Reprinted with permission from Bressler NM, Bressler SB, Fine SL 1988. Age-related macular degeneration. Surv Ophthalmol, 32:375–413. © 1998 Elsevier.
Figure 2
Figure 2
The vascular and nonvascular theory of AMD. The vascular theory, suggested by Friedman (1997), states that with increased resistance in the choroidal vessels, there is an increase in the osmotic gradient against which the retinal pigment epithelial cells must pump. This leads to retinal pigment epithelial cell dysfunction and the accumulation of metabolic debris and drusen formation. Furthermore, the decrease in choroidal perfusion causes ischemic/hypoxic injury and increased oxidative stress, which can signal choroidal neovascularization formation. On the other hand, in the nonvascular theory, senescent retinal pigment epithelial cells can lead to retinal pigment epithelial cell dysfunction, which in turn can cause choriocapillary atrophy. Over time, and individual’s genetic predisposition and environmental stressors in the setting of structural and vascular changes make the eye more susceptible to AMD development.

References

    1. Andreoli CM, Miller JW. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol. 2007;18:502–8. - PubMed
    1. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol. 2001;119:1417–36. - PMC - PubMed
    1. Bhutto IA, McLeod DS, Hasegawa T, et al. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res. 2006;82:99–110. - PMC - PubMed
    1. Bird JC, Marshall J. Retinal pigment epithelial detachments in the elderly. Trans Soc Ophthalmol UK. 1986;105:674–82. - PubMed
    1. Boehm AG, Koeller AU, Pillunat LE. The effect of age on optic nerve head blood flow. Invest Ophthalmol Vis Sci. 2005;46:1291–5. - PubMed

Publication types